B. Xu

KEAP1/NFE2L2 Mutations of Liquid Biopsy as Prognostic Biomarkers in Patients With Advanced Non-Small Cell Lung Cancer: Results From Two Multicenter, Randomized Clinical Trials

Lawrence W. C. Chan, Haiyu Zhou, G. Qiao, 2021, Frontiers in Oncology.

Novel MRPS9-ALK Fusion Mutation in a Lung Adenocarcinoma Patient: A Case Report

Yong Guo, G. Zhu, Bin Xu, 2021, Frontiers in Oncology.

A cascade dual-targeted nanocarrier for enhanced alectinib delivery to ALK-positive lung cancer.

Haiyu Zhou, Xianzhu Yang, G. Qiao, 2020, Biomaterials science.